The partnership gives the German pharmaceutical company access to one of the country's leading academic and biotech networks focused on nucleic acid therapeutics
With new distribution agreements in Argentina, Hong Kong & Singapore
Lilly will also gain VLS-01, a buccal film formulation of DMT currently in Phase 2b testing, along with AtaiBeckley's broader pipeline of next-generation neuroplastogens aimed at restoring the brain's ability to form new neural connections
The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Subscribe To Our Newsletter & Stay Updated
